Regulus Therapeutics (NASDAQ:RGLS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Regulus Therapeutics (RGLS) operate in?

Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Regulus Therapeutics Stock (NASDAQ: RGLS) stock price, news, charts, stock research, profile.

Open	$1.53
Close	$1.59
Volume / Avg.	462.27K / 362.99K
Day Range	$1.51 - $1.60
52 Wk Range	1.08 - 3.79
Market Cap	$104.15M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	2.72%
Days to Cover	5.41

Recent News

Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

What's Going On With Regulus Therapeutics Stock Monday?

Regulus Therapeutics announced positive results from its study related to the treatment of autosomal dominant polycystic kidney disease (AKPD).

Dylan Berman

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.53
Close	$1.59
Volume / Avg.	462.27K / 362.99K
Day Range	$1.51 - $1.60
52 Wk Range	1.08 - 3.79
Market Cap	$104.15M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	2.72%
Days to Cover	5.41

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Regulus Therapeutics (RGLS) stock?

You can purchase shares of Regulus Therapeutics (NASDAQ:RGLS) through any online brokerage.

View our list of the best stock brokerages

Who are Regulus Therapeutics (RGLS) competitors?

Other companies in Regulus Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE) and Tonix Pharmaceuticals (NASDAQ:TNXP).

What is the forecast, or price target, for Regulus Therapeutics (RGLS) stock?

Regulus Therapeutics has a consensus price target of $10.33.

What is the current price for Regulus Therapeutics (RGLS)?

The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $1.59 last updated December 20, 2024 at 4:00 PM EST.

Does Regulus Therapeutics (RGLS) pay a dividend?

There are no upcoming dividends for Regulus Therapeutics.

When is Regulus Therapeutics (NASDAQ:RGLS) reporting earnings?

Regulus Therapeutics’s Q4 earnings are confirmed for Thursday, March 20, 2025.

Is Regulus Therapeutics (RGLS) going to split?

There is no upcoming split for Regulus Therapeutics.

What sector and industry does Regulus Therapeutics (RGLS) operate in?

Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Regulus Therapeutics

Regulus Therapeutics (RGLS) Forecast